​
​

Addex Therapeutics (ADXN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Addex Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.61M

Latest Revenue (Q)

$235.00K

Main Segment (Y)

Research

Addex Therapeutics Revenue by Period

Addex Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$1.61M13.39%
2022-12-31$1.42M-51.22%
2021-12-31$2.92M-19.28%
2020-12-31$3.61M30.77%
2019-12-31$2.76M-54.29%
2018-12-31$6.04M100.00%
2017-12-31--100.00%
2016-12-31$17.33K-57.00%
2015-12-31$40.30K-52.81%
2014-12-31$85.40K-6.93%
2013-12-31$91.76K100.00%
2012-12-31--100.00%
2011-12-31$2.82M42.94%
2010-12-31$1.98M-51.71%
2009-12-31$4.09M-84.74%
2008-12-31$26.81M5405.28%
2007-12-31$486.93K-89.72%
2006-12-31$4.74M-

Addex Therapeutics generated $1.61M in revenue during NA 2023, up 13.39% compared to the previous quarter, and up 26.69% compared to the same period a year ago.

Addex Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31$235.00K53.14%
2023-12-31$153.45K-53.18%
2023-09-30$327.73K-48.05%
2023-06-30$630.88K25.95%
2023-03-31$500.89K-15.45%
2022-12-31$592.43K44.70%
2022-09-30$409.42K123.29%
2022-06-30$183.35K-22.71%
2022-03-31$237.24K-40.32%
2021-12-31$397.49K-41.72%
2021-09-30$682.00K-31.29%
2021-06-30$992.60K17.57%
2021-03-31$844.22K-53.63%
2020-12-31$1.82M6578.04%
2020-09-30$27.26K-96.83%
2020-06-30$860.79K-4.79%
2020-03-31$904.06K-13.09%
2019-12-31$1.04M107.06%
2019-09-30$502.36K-3.29%
2019-06-30$519.43K-25.89%
2019-03-31$700.87K4.98%
2018-12-31$667.61K-0.00%
2018-09-30$667.61K-75.12%
2018-06-30$2.68M-
2018-03-31$2.68M1865.16%
2017-12-31$136.56K-
2017-09-30$136.56K20.45%
2017-06-30$113.38K-
2017-03-31$113.38K76.81%
2016-12-31$64.13K-
2016-09-30$64.13K-54.76%
2016-06-30$141.75K-
2016-03-31$141.75K-

Addex Therapeutics generated $235.00K in revenue during Q1 2024, up 53.14% compared to the previous quarter, and up 39.67% compared to the same period a year ago.

Addex Therapeutics Revenue Breakdown

Addex Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Research$1.60M$1.40M$2.90M--
Ifrs Research---$3.60M$2.80M

Addex Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research (100.00%).

Addex Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IPHAInnate Pharma$51.90M$16.56M
KRONKronos Bio$6.29M$2.37M
DYAIDyadic$2.90M$1.96M
ADXNAddex Therapeutics$1.61M$235.00K
SNGXSoligenix$839.36K-
ACHLAchilles Therapeutics--
LRMRLarimar Therapeutics--
ERYPPHAXIAM Therapeutics--
ATXIAvenue Therapeutics--
CYCNCyclerion Therapeutics-$194.00K

ADXN Revenue FAQ

What is Addex Therapeutics’s yearly revenue?

Addex Therapeutics's yearly revenue for 2023 was $1.61M, representing an increase of 13.39% compared to 2022. The company's yearly revenue for 2022 was $1.42M, representing a decrease of -51.22% compared to 2021. ADXN's yearly revenue for 2021 was $2.92M, representing a decrease of -19.28% compared to 2020.

What is Addex Therapeutics’s quarterly revenue?

Addex Therapeutics's quarterly revenue for Q1 2024 was $235K, a 53.14% increase from the previous quarter (Q4 2023), and a -53.08% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $153.45K, a -53.18% decrease from the previous quarter (Q3 2023), and a -74.10% decrease year-over-year (Q4 2022). ADXN's quarterly revenue for Q3 2023 was $327.73K, a -48.05% decrease from the previous quarter (Q2 2023), and a -19.95% decrease year-over-year (Q3 2022).

What is Addex Therapeutics’s revenue growth rate?

Addex Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -44.69%, and for the last 5 years (2019-2023) was -41.62%.

What are Addex Therapeutics’s revenue streams?

Addex Therapeutics's revenue streams in c 23 are Research

What is Addex Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Addex Therapeutics was Research. This segment made a revenue of $1.6M, representing 100.00% of the company's total revenue.